What is Limbix?
Limbix is a pioneering prescription digital therapeutic company dedicated to developing innovative mental health treatments specifically for adolescents. The company's strength lies in its multidisciplinary team, comprising clinicians, product designers, researchers, and engineers, who synergistically combine clinical expertise with technological advancements. Their flagship digital therapeutic, SparkRx by Limbix, is now accessible to licensed healthcare professionals nationwide, offering a scalable solution for adolescent mental well-being.
How much funding has Limbix raised?
Limbix has raised a total of $24M across 2 funding rounds:
Series A
$9M
Series A
$15M
Series A (2020): $9M with participation from BIXINK Therapeutics, GSR Ventures, NEXTGEN ANGELS, LLC, Sequoia Capital companies, and Storm Ventures Group
Series A (2021): $15M led by Digital Garage and GSR Ventures
Key Investors in Limbix
BIXINK Therapeutics
An entity involved in the funding round for Limbix. Further details on their investment focus are not publicly available.
GSR Ventures
GSR Ventures is a venture capital firm that typically invests in technology and innovation. Their participation in Limbix's funding round suggests a focus on digital health solutions and companies with strong technological underpinnings.
NEXTGEN ANGELS, LLC
An angel investment group that supports early-stage companies. Their involvement indicates confidence in Limbix's foundational technology and market opportunity.
What's next for Limbix?
With the recent major strategic investment, Limbix is poised for significant expansion and product development. This capital infusion is anticipated to fuel the enhancement of their existing digital therapeutics and the research and development of new solutions targeting the adolescent mental health crisis. The company's focus on integrating clinical rigor with technological innovation suggests a strategic direction towards broader market penetration and establishing new standards in digital mental healthcare delivery.
See full Limbix company page
